Research Outlines Benefits of bDMARDs to Treat Early RA

Michele B. Kaufman, PharmD, BCGP, is a freelance medical writer based in New York City and a pharmacist at New York Presbyterian Lower Manhattan Hospital.

Reference

1. Sapart E, Sokolova T, de Montjoye S, et al. Should we use bioDMARDs in first intention in early rheumatoid arthritis? Results at 5 years from the ERA Louvain Brussels Cohort [abstract 0221]. Arthritis Rheumatol. 2020 Oct; 72(suppl 10).